4-Pyrimidinamine, N-[3-(4-methoxyphenyl)-5-isoxazolyl]-2-(4-morpholinyl)- - Names and Identifiers
4-Pyrimidinamine, N-[3-(4-methoxyphenyl)-5-isoxazolyl]-2-(4-morpholinyl)- - Physico-chemical Properties
Molecular Formula | C18H19N5O3
|
Molar Mass | 353.38 |
Density | 1.306±0.06 g/cm3(Predicted) |
Boling Point | 627.9±65.0 °C(Predicted) |
Solubility | Soluble in DMSO (>25 mg/ml) |
Appearance | solid |
Color | Off-white |
pKa | 6.69±0.10(Predicted) |
Storage Condition | -20°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
4-Pyrimidinamine, N-[3-(4-methoxyphenyl)-5-isoxazolyl]-2-(4-morpholinyl)- - Preparation solution concentration reference
| 1mg | 5mg | 10mg |
---|
1 mM | 2.83 ml | 14.149 ml | 28.298 ml |
5 mM | 0.566 ml | 2.83 ml | 5.66 ml |
10 mM | 0.283 ml | 1.415 ml | 2.83 ml |
5 mM | 0.057 ml | 0.283 ml | 0.566 ml |
Last Update:2024-01-02 23:10:35
4-Pyrimidinamine, N-[3-(4-methoxyphenyl)-5-isoxazolyl]-2-(4-morpholinyl)- - Reference Information
biological activity | BO-264 is an effective oral inhibitor transforming acidic coiled-coil 3 (TACC3) with IC50 value of 188 nM and Kd value of 1.5 nM. BO-264 can specifically block the function of FGFR3-TACC3 fusion protein. BO-264 can induce SAC-dependent mitotic arrest, apoptosis and DNA damage with anti-tumor activity. |
Target | Value |
FGFR3
()
| |
TACC3
(Cell-free assay)
| 1.5 nM(Kd) 188 nM |
Last Update:2024-04-10 22:29:15